WASHINGTON — Drugmaker Moderna requested the Food and Drug Administration on Thursday to authorize a fourth shot of its Covid-19 vaccine as a booster dose for all adults.
The request is broader than rival pharmaceutical firm Pfizer’s request earlier this week for the regulator to approve a booster shot for all seniors.
In a news launch, the corporate stated its request for approval for all adults was made “to provide flexibility” to the Centers for Disease Control and Prevention and medical suppliers to decide the “appropriate use” of a second booster dose of the mRNA vaccine, “including for those at higher risk of COVID-19 due to age or comorbidities.”
U.S. officers have been laying the groundwork to ship further booster doses to shore up the vaccines’ safety towards critical illness and dying from COVID-19.
The White House has been sounding the alarm that it wants Congress to “urgently” approve extra funding for the federal authorities to safe extra doses of the COVID-19 vaccines, both for further booster photographs or variant-specific immunizations.
